This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Canada Inc.. Active years: 2013-2017.
Company Filing History:
3 out of 2,405 
1 out of 40 
Years Active: 2013-2017
Title: Unveiling the Inventive Journey of Matthew L Maddess
Introduction:
Matthew L Maddess, a brilliant inventor hailing from Boston, MA (US), has made remarkable contributions to the world of innovations with his groundbreaking inventions. With a portfolio boasting three patents, Maddess stands out as a pioneering force in the realm of pharmaceutical advancements.
Latest Patents:
1. "2-pyrazine carboxamides as spleen tyrosine kinase inhibitors": Maddess's inventive genius shines through in this patent, which introduces novel pyrazine-2-carboxamide compounds for treating diseases mediated by Spleen Tyrosine Kinase (Syk).
2. "Pyrazolyl derivatives as Syk inhibitors": Another milestone in Maddess's career, this patent showcases his development of potent inhibitors of spleen tyrosine kinase, offering promising avenues in the treatment of various conditions like asthma, COPD, rheumatoid arthritis, and cancer.
Career Highlights:
With a diverse professional journey, Matthew L Maddess has lent his expertise to renowned companies such as Merck Sharp & Dohme Corporation and Merck Canada Inc., where he has played a pivotal role in driving cutting-edge research and development initiatives.
Collaborations:
During his career, Maddess has collaborated closely with accomplished individuals in the field of pharmaceutical innovations, including esteemed coworkers like Michael D Altman and Brandon D Cash. These collaborations have further enriched his inventiveness and propelled his contributions to new heights.
Conclusion:
In conclusion, Matthew L Maddess's inventive spirit and dedication to advancing pharmaceutical solutions have cemented his legacy as a trailblazing inventor. His patents not only demonstrate his technical prowess but also underscore his commitment to improving healthcare outcomes through innovative discoveries.